Study summary

The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.

Additional Study Details

Phase
4
Product
N/A
Product
Advagraf
Mycophenolate Mofetil
Simulect
Corticosteroids
Type
Interventional
Masking
None (Open Label)
Enrollment number
1166
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study looking at Diabetes in Kidney Transplant recipients receiving Immunosuppressive regimen with or without steroids? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Withdrawn
    Kemerovo, Russian Federation, 650066
    Completed
    Vicenza, Italy, 36100
    Completed
    L'Aquila, Italy, 67010
    Completed
    Riga, Latvia, LV-1002
    Completed
    Cuernavaca, Mexico, 62448
    Completed
    Bucharest, Romania, 022328
    Completed
    Rennes, France, 35033
    Completed
    Olso, Norway, 0027
    Withdrawn
    Szczecin, Poland, 71-450
    Completed
    Goteborg, Sweden, 41345
    Completed
    Tartu, Estonia, 51014
    Completed
    Bonn, Germany, 53105
    Completed
    Kosice, Slovakia, 040 66
    Completed
    Suresnes, France, 92151
    Completed
    Moscow, Russian Federation, 115446
    Completed
    Sydney, Australia, 2050
    Withdrawn
    Moscow, Russian Federation, 123182
    Completed
    Helsinki, Finland, 02611
    Completed
    Kaiserslautern, Germany, 67655
    Completed
    Leuven, Belgium, 3000
    Completed
    Prague, Czech Republic, 140 21
    Completed
    Bruxelles, Belgium, 1200
    Completed
    Cali, Colombia, 760032
    Completed
    Halle Saale, Germany, 06120
    Completed
    Mannheim, Germany, 68167
    Completed
    Treviso, Italy, 31100
    Withdrawn
    Sao Paulo, Brazil, 04038-002
    Withdrawn
    St. Gallen, Switzerland, 9007
    Withdrawn
    Sao Paulo, Brazil, 01323-030
    Completed
    Sydney, Australia, 2145
    Completed
    Ancona, Italy, 60020
    Completed
    Stockholm, Sweden, 141 86
    Completed
    Regensburg, Germany, 93053
    Completed
    Madrid, Spain, 28041
    Completed
    Barcelona, Spain, 08035
    Completed
    Liege, Belgium, 4000
    Completed
    Bydgoszcz, Poland, 85-094
    Completed
    Seoul, Republic of Korea, 138-736
    Completed
    Moscow, Russian Federation, 129110
    Completed
    Bordeaux, France, 33076
    Withdrawn
    Mexico City, Mexico, 14080
    Completed
    Szczecin, Poland, 70-111
    Withdrawn
    Wroclaw, Poland, 50-417
    Completed
    Montpellier, France, 34295
    Completed
    Strasbourg, France, 67091
    Completed
    Saint-Petersburg, Russian Federation, 197022
    Completed
    Mexico City, Mexico, 14000
    Completed
    Essen, Germany, 45147
    Completed
    Barcelona, Spain, 08916
    Completed
    Roma, Italy, 00133
    Completed
    Milano, Italy, 20162
    Completed
    Vilnius, Lithuania, LT-08661
    Completed
    Porto, Portugal, 4099-001
    Completed
    D'Angers, France, 49033
    Withdrawn
    Berlin, Germany, 13353
    Withdrawn
    Rio de Janeiro, Brazil, 21040-030
    Completed
    Banska Bystrica, Slovakia, 975 17
    Completed
    Salerno, Italy, 84131
    Completed
    Uppsala, Sweden, 75185
    Completed
    Cite Nord, France, 42270
    Completed
    Lisboa, Portugal, 1649-035
    Completed
    Moscow, Russian Federation, 119992
    Completed
    Nizhniy Novgorod, Russian Federation, 603001
    Completed
    Sevilla, Spain, 41013
    Completed
    Nice, France, 06002
    Completed
    Hradec Kralove, Czech Republic, 50005
    Completed
    Debrecen, Hungary, 4032
    Completed
    Bratislava, Slovakia, 833 05
    Completed
    Brussels, Belgium, 1090
    Completed
    Szeged, Hungary, 6720
    Completed
    Aachen, Germany, 52074
    Completed
    Alicante, Spain, 03010
    Completed
    Rostock, Germany, 18055
    Completed
    Bologna, Italy, 40138
    Completed
    Nantes, France, 49033
    Completed
    Lasi, Romania, 700503
    Completed
    Cagliari, Italy, 09134
    Completed
    Le Puytren, France, 87042
    Withdrawn
    Kiel, Germany, 24105
    Completed
    Cordoba, Spain, 14004
    Completed
    Perth, Australia, 6001
    Completed
    Valladolid, Spain, 47011
    Withdrawn
    Krasnodar, Russian Federation, 350086
    Completed
    Omsk, Russian Federation, 644112
    Withdrawn
    Saint-Petersburg, Russian Federation, 197110
    Completed
    Paris, France, 75970
    Completed
    Bern, Switzerland, 3010
    Completed
    Santa Cruz de Tenerife, Spain, 38320
    Completed
    Brno, Czech Republic, 656 91
    Completed
    Padova, Italy, 35128
    Completed
    Saint-Petersburg, Russian Federation, 192242
    Completed
    Coimbra, Portugal, 3000-075
    Completed
    Gdansk, Poland, 80-952
    Completed
    Poznan, Poland, 60-479
    Completed
    Maastricht, Netherlands, 6229 HX
    Completed
    Moscow, Russian Federation, 129090
    Completed
    Olomouc, Czech Republic, 775 20
    Completed
    Ekaterinburg, Russian Federation, 620102
    Completed
    Düsseldorf, Germany, 40225
    Completed
    Pisa, Italy, 56124
    Completed
    Rouen, France, 76320
    Completed
    Valencia, Spain, 46009
    Completed
    Milano, Italy, 20132
    Completed
    Toledo, Spain, 45004
    Completed
    Muenchen, Germany, 81675
    Withdrawn
    Curitiba, Brazil, 80240-000
    Completed
    Madrid, Spain, 28034
    Completed
    Vol'skiy, Russian Federation, 404120
    Completed
    Warszawa, Poland, 02-006

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?